57 results
8-K
EX-99.2
FOLD
Amicus Therapeutics Inc
28 Feb 24
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
7:02am
, Social, & Governance (ESG) Snapshot Board of Directors Committed to ongoing Board refreshment and diversity of background, gender, skills, and experience
8-K
EX-99.2
FOLD
Amicus Therapeutics Inc
8 Jan 24
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
7:01am
OTHER Discovery Programs
31 Environmental, Social, & Governance (ESG) Snapshot Board of Directors Committed to ongoing Board refreshment
S-3ASR
FOLD
Amicus Therapeutics Inc
8 Nov 23
Automatic shelf registration
5:25pm
environmental, social and governance standards;
our ability to accurately forecast revenue, operating expenditures, or other metrics impacting profitability
8-K
EX-99.2
dn8coqc07 pl9umooi
8 Nov 23
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
w3k drvw9084v0d
2 Oct 23
Entry into a Material Definitive Agreement
8:48am
8-K
EX-99.1
jn7dhtz 293ya6zfb3
27 Sep 23
AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Corporate Overview September 2023
7:00am
8-K
EX-99.2
j279eg7b88 qiugt
8 Aug 23
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
7:00am
8-K
EX-10.1
thkvgd2x9egc
12 May 23
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-99.2
t086s 4z6edn3
10 May 23
Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates
7:01am
8-K
EX-99.1
pj3frzcvn8b
16 Nov 22
Corporate OverviewNovember 2022At the Forefront of Therapies for Rare Diseases
7:01am
424B5
m3fzr
7 Nov 22
Prospectus supplement for primary offering
7:11am